OPG dose dependently neutralizes the promigratory activity of TRAIL [27], so the high levels of OPG observed in diabetic patients might impair the pro-migratory signalling driven by TRAIL, accounting for the abnormalities of BM-SC in DM. Here, TNFSF10 is linked to diabetes mellitus.